Goldman Sachs’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $786M | Sell |
8,571,015
-904,819
| -10% | -$79.2M | 0.07% | 273 |
|
|
2026
Q1 | $808M | Buy |
9,475,834
+3,982,104
| +72% | +$355M | 0.09% | 206 |
|
|
2025
Q4 | $434M | Sell |
5,493,730
-1,460,570
| -21% | -$115M | 0.05% | 346 |
|
|
2025
Q3 | $556M | Sell |
6,954,300
-574,495
| -8% | -$49M | 0.07% | 269 |
|
|
2025
Q2 | $684M | Sell |
7,528,795
-401,592
| -5% | -$36.7M | 0.09% | 203 |
|
|
2025
Q1 | $743M | Buy |
7,930,387
+1,995,191
| +34% | +$179M | 0.12% | 153 |
|
|
2024
Q4 | $540M | Sell |
5,935,196
-2,672,174
| -31% | -$255M | 0.09% | 209 |
|
|
2024
Q3 | $894M | Buy |
8,607,370
+1,731,324
| +25% | +$176M | 0.14% | 131 |
|
|
2024
Q2 | $667M | Buy |
6,876,046
+1,414,855
| +26% | +$131M | 0.11% | 171 |
|
|
2024
Q1 | $492M | Buy |
5,461,191
+783,090
| +17% | +$66.3M | 0.09% | 225 |
|
|
2023
Q4 | $373M | Buy |
4,678,101
+1,360,425
| +41% | +$102M | 0.07% | 288 |
|
|
2023
Q3 | $236M | Sell |
3,317,676
-380,150
| -10% | -$28.4M | 0.05% | 370 |
|
|
2023
Q2 | $285M | Buy |
3,697,826
+24,973
| +0.7% | +$1.93M | 0.06% | 311 |
|
|
2023
Q1 | $276M | Buy |
3,672,853
+216,508
| +6% | +$16.1M | 0.06% | 313 |
|
|
2022
Q4 | $272M | Buy |
3,456,345
+220,778
| +7% | +$16.6M | 0.07% | 318 |
|
|
2022
Q3 | $227M | Buy |
3,235,567
+353,515
| +12% | +$27.7M | 0.06% | 347 |
|
|
2022
Q2 | $231M | Buy |
2,882,052
+293,536
| +11% | +$23M | 0.06% | 344 |
|
|
2022
Q1 | $196M | Sell |
2,588,516
-1,199,554
| -32% | -$95M | 0.04% | 440 |
|
|
2021
Q4 | $323M | Buy |
3,788,070
+581,927
| +18% | +$45.4M | 0.06% | 305 |
|
|
2021
Q3 | $242M | Buy |
3,206,143
+398,715
| +14% | +$31.7M | 0.05% | 355 |
|
|
2021
Q2 | $228M | Buy |
2,807,428
+173,788
| +7% | +$14.2M | 0.05% | 351 |
|
|
2021
Q1 | $208M | Buy |
2,633,640
+428,489
| +19% | +$33.6M | 0.05% | 359 |
|
|
2020
Q4 | $189M | Sell |
2,205,151
-793,927
| -26% | -$65.7M | 0.05% | 351 |
|
|
2020
Q3 | $231M | Buy |
2,999,078
+25,645
| +0.9% | +$1.96M | 0.07% | 288 |
|
|
2020
Q2 | $218M | Sell |
2,973,433
-212,304
| -7% | -$15.1M | 0.07% | 282 |
|
|
2020
Q1 | $211M | Sell |
3,185,737
-1,289,511
| -29% | -$90.9M | 0.07% | 252 |
|
|
2019
Q4 | $308M | Buy |
4,475,248
+220,215
| +5% | +$15M | 0.08% | 268 |
|
|
2019
Q3 | $313M | Sell |
4,255,033
-1,248,909
| -23% | -$90.6M | 0.09% | 221 |
|
|
2019
Q2 | $394M | Buy |
5,503,942
+354,783
| +7% | +$25.2M | 0.11% | 167 |
|
|
2019
Q1 | $353M | Buy |
5,149,159
+1,173,581
| +30% | +$75.8M | 0.11% | 177 |
|
|
2018
Q4 | $237M | Sell |
3,975,578
-1,498,155
| -27% | -$93.7M | 0.08% | 261 |
|
|
2018
Q3 | $366M | Sell |
5,473,733
-107,763
| -2% | -$7.18M | 0.09% | 209 |
|
|
2018
Q2 | $362M | Sell |
5,581,496
-2,231,316
| -29% | -$146M | 0.1% | 195 |
|
|
2018
Q1 | $560M | Sell |
7,812,812
-592,679
| -7% | -$42.7M | 0.14% | 134 |
|
|
2017
Q4 | $634M | Buy |
8,405,491
+1,095,369
| +15% | +$80M | 0.15% | 112 |
|
|
2017
Q3 | $533M | Buy |
7,310,122
+1,532,814
| +27% | +$110M | 0.13% | 135 |
|
|
2017
Q2 | $428M | Buy |
5,777,308
+329,850
| +6% | +$24.5M | 0.11% | 161 |
|
|
2017
Q1 | $399M | Buy |
5,447,458
+989,847
| +22% | +$69.3M | 0.11% | 160 |
|
|
2016
Q4 | $292M | Buy |
4,457,611
+1,475,912
| +49% | +$101M | 0.08% | 236 |
|
|
2016
Q3 | $221M | Sell |
2,981,699
-353,710
| -11% | -$26.1M | 0.07% | 308 |
|
|
2016
Q2 | $244M | Sell |
3,335,409
-1,023,760
| -23% | -$72.9M | 0.08% | 266 |
|
|
2016
Q1 | $308M | Sell |
4,359,169
-546,295
| -11% | -$36.3M | 0.1% | 191 |
|
|
2015
Q4 | $327M | Sell |
4,905,464
-1,096,464
| -18% | -$72.9M | 0.1% | 198 |
|
|
2015
Q3 | $381M | Buy |
6,001,928
+742,522
| +14% | +$48.5M | 0.13% | 138 |
|
|
2015
Q2 | $344M | Sell |
5,259,406
-968,691
| -16% | -$65.7M | 0.11% | 188 |
|
|
2015
Q1 | $432M | Buy |
6,228,097
+951,684
| +18% | +$65.8M | 0.14% | 138 |
|
|
2014
Q4 | $365M | Sell |
5,276,413
-114,445
| -2% | -$7.73M | 0.12% | 172 |
|
|
2014
Q3 | $352M | Sell |
5,390,858
-990,514
| -16% | -$65.3M | 0.11% | 164 |
|
|
2014
Q2 | $435M | Buy |
6,381,372
+162,422
| +3% | +$10.9M | 0.14% | 136 |
|
|
2014
Q1 | $403M | Buy |
6,218,950
+920,896
| +17% | +$58M | 0.13% | 145 |
|
|
2013
Q4 | $345M | Buy |
5,298,054
+2,590,419
| +96% | +$166M | 0.11% | 175 |
|
|
2013
Q3 | $161M | Sell |
2,707,635
-212,696
| -7% | -$12.6M | 0.06% | 365 |
|
|
2013
Q2 | $167M | Buy |
+2,920,331
| New | +$173M | 0.06% | 343 |
|
Other funds holding CL
Goldman Sachs's CL Position: Q2 2026 in Review
Goldman Sachs reduced its Colgate-Palmolive (CL) stake by 9.5% in Q2 2026, selling an estimated $79.2M and leaving 8,571,015 shares worth $786M. The position accounts for 0.07% of the portfolio, ranked #273.
Goldman Sachs first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $894M in Q3 2024. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Goldman Sachs held 8,571,015 shares of Colgate-Palmolive worth $786M as of Q2 2026.
- Goldman Sachs sold 904,819 Colgate-Palmolive shares in Q2 2026, an estimated $79.2M.
- Colgate-Palmolive made up 0.07% of Goldman Sachs's portfolio in Q2 2026, its #273 holding.
- Goldman Sachs first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Colgate-Palmolive position peaked at $894M in Q3 2024.
- 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.